LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

The new Osia® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 Tesla (T) without the need for surgery This has been made possible by the OSI300's unique Piezo Power™ technology ...

The new Cochlear™ Nucleus® Nexa® System is the first and only hearing implant featuring internal memory and upgradeable firmware. Approximately 63 million people in India suffer from significant ...

BOAO, China, June 20, 2025 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa™ System - the world's first and only smart cochlear ...

LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...

The Aussie biotech has warned on its business in developed markets as it expects a turnaround in services revenue in FY26. The near-$18bn group is now guiding to an underlying net profit of between ...

Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, 18-month-old Nene Gudavadze is responding to sound, dancing to music, and ...

Built on a completely new microchip platform with five times the processing power of the market-leading Nucleus 5 Sound Processor, the Nucleus 6 System introduces a range of industry first innovations ...

Upgradeable Firmware: The Cochlear™ Nucleus ® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.

Xinyu Li, General Manager, Greater China, Cochlear, explains the next generation technology has completely reimagined the internal components of the hearing device: "There are more than 10 years of ...

The near-$18bn group is now guiding to an underlying net profit of between $390m and $400m, comparing to its FY24 result of $386.6m. At the time of its first-half results release in February, Cochlear ...